ORIGINAL RESEARCH article
Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1464613
This article is part of the Research TopicMicrobial Resistance and Infection Control in Public Health Care SettingView all 11 articles
Use of Multiple Metrics and Clustering Analysis to Assess Antimicrobial Use in Shanxi Hospitals, China: A Cross-Sectional Study Based on 25 General Hospitals
Provisionally accepted- 1Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China, Taiyuan, China
- 2Department of Pharmacy, The Affiliated Tianfu Hospital of Southwest Medical University, Meishan,Sichuan,People’s Republic of China, Meishan, China
- 3Department of Pharmacy, School of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China, Taiyuan, Shanxi Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To investigate the current patterns of antimicrobial use among nonsurgical inpatients across 25 general hospitals in Shanxi Province and to evaluate the antimicrobial use rate, antimicrobial use density (AUD), days of therapy (DOT), length of therapy (LOT), and the application of cluster analysis in monitoring antimicrobial prescribing practices. Methods: This study included 25 general hospitals covering 11 cities in Shanxi Province. In total, 2064 hospitalized nonsurgical patients were evaluated for antimicrobial use between December 1, 2022, and January 31, 2023. Data collected included the proportion of antimicrobial prescriptions, antimicrobial use rate, AUD, DOT, and LOT. Statistical analyses were conducted using IBM SPSS version 21.0. Cluster analysis was employed to categorize the 25 hospitals systematically. Results: Among the hospitals, the antimicrobial utilization rate ranged from 43.00% to 83.33%. The intensity of antimicrobial use ranged from 40DDDs/ 100pd to 98.99DDDs/100pd. DOT values ranged from 380/1000pd to 713/1000pd, while LOT ranged from 425/1000pd to 1014/1000pd.The top three antimicrobial classes by AUD were third-generation cephalosporins (15.38 DDDs/100pd), quinolones (13.60 DDDs/100pd), and cephalosporins (11.54 DDDs/100pd). The ICU had the highest antimicrobial use rate and AUD-91.67% and 133.28 DDDs/100pd, respectively -and the longest DOT (1230/1000 pd). The infection department recorded the highest LOT (988/1000pd). In pediatrics, the AUD and DOT were 53.77DDDs/ 100pd and 1106/1000pd, respectively. The 25 hospitals were grouped into three distinct clusters via cluster analysis. Statistically significant differences in some antimicrobial indicators were observed among the groups (P < 0.05).Conclusions: Across the 25 hospitals, the rate and intensity of antimicrobial use were relatively high in institutions and departments. During the study period, the use of cefoperazone/sulbactam and fluoroquinolones increased. Concurrently, the combined use of AUD and DOT provided complementary perspectives for evaluating antimicrobial consumption, allowing for a more comprehensive understanding of exposure levels across hospitals and departments. Cluster analysis provides valuable insights for identifying patterns into antimicrobial management and usage.
Keywords: Antimicrobial use, Public hospitals, Antimicrobial stewardship, Clustering analysis, Retrospective study
Received: 14 Jul 2024; Accepted: 30 Jul 2025.
Copyright: © 2025 Yin, Tang, Wang, Wang, Hou and Duan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ruigang Hou, Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China, Taiyuan, China
Jinju Duan, Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China, Taiyuan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.